The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?


Sen S., Tuncer A., ÖZAKBAŞ S., Uzunkopru C., Baba C., Demir S., ...Daha Fazla

MULTIPLE SCLEROSIS AND RELATED DISORDERS, cilt.58, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.msard.2021.103399
  • Dergi Adı: MULTIPLE SCLEROSIS AND RELATED DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Anahtar Kelimeler: Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.